Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/8c/da/ae/8cdaae52-b058-52f6-2faa-cf796797a006/mza_9342844741255296514.jpg/600x600bb.jpg
Precision Signals
Sean Khozin, MD, MPH
4 episodes
2 weeks ago
Precision Signals is a podcast from the CEO Roundtable on Cancer about decoding biomedical progress: what’s real, what matters, and what’s next. We talk with scientists, regulators, investors, and builders operating across the messy interface of research, healthcare, and policy. Some are moving the system from within; others are reshaping it from the outside. All of them bring signal in a world crowded with noise.
Show more...
Life Sciences
Business,
Investing,
Health & Fitness,
Medicine,
Science
RSS
All content for Precision Signals is the property of Sean Khozin, MD, MPH and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Precision Signals is a podcast from the CEO Roundtable on Cancer about decoding biomedical progress: what’s real, what matters, and what’s next. We talk with scientists, regulators, investors, and builders operating across the messy interface of research, healthcare, and policy. Some are moving the system from within; others are reshaping it from the outside. All of them bring signal in a world crowded with noise.
Show more...
Life Sciences
Business,
Investing,
Health & Fitness,
Medicine,
Science
https://artwork.captivate.fm/3f50a540-5667-4c35-b43b-2e9c46c59f03/Gulley.jpg
Endpoints, Resistance, and the Architecture of Evidence in Immuno-Oncology
Precision Signals
53 minutes 18 seconds
2 months ago
Endpoints, Resistance, and the Architecture of Evidence in Immuno-Oncology
Precision Signals
Precision Signals is a podcast from the CEO Roundtable on Cancer about decoding biomedical progress: what’s real, what matters, and what’s next. We talk with scientists, regulators, investors, and builders operating across the messy interface of research, healthcare, and policy. Some are moving the system from within; others are reshaping it from the outside. All of them bring signal in a world crowded with noise.